1. Home
  2. GNFT vs XBIT Comparison

GNFT vs XBIT Comparison

Compare GNFT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • XBIT
  • Stock Information
  • Founded
  • GNFT 1999
  • XBIT 2005
  • Country
  • GNFT France
  • XBIT United States
  • Employees
  • GNFT N/A
  • XBIT N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • XBIT Pharmaceuticals and Biotechnology
  • Sector
  • GNFT Health Care
  • XBIT Health Care
  • Exchange
  • GNFT Nasdaq
  • XBIT Nasdaq
  • Market Cap
  • GNFT 249.0M
  • XBIT 242.2M
  • IPO Year
  • GNFT 2019
  • XBIT 2015
  • Fundamental
  • Price
  • GNFT $6.03
  • XBIT $7.52
  • Analyst Decision
  • GNFT Strong Buy
  • XBIT
  • Analyst Count
  • GNFT 1
  • XBIT 0
  • Target Price
  • GNFT $13.00
  • XBIT N/A
  • AVG Volume (30 Days)
  • GNFT 27.9K
  • XBIT 50.6K
  • Earning Date
  • GNFT 09-19-2024
  • XBIT 11-07-2024
  • Dividend Yield
  • GNFT N/A
  • XBIT N/A
  • EPS Growth
  • GNFT N/A
  • XBIT N/A
  • EPS
  • GNFT 0.47
  • XBIT N/A
  • Revenue
  • GNFT $86,225,222.00
  • XBIT N/A
  • Revenue This Year
  • GNFT $155.44
  • XBIT N/A
  • Revenue Next Year
  • GNFT N/A
  • XBIT N/A
  • P/E Ratio
  • GNFT $12.48
  • XBIT N/A
  • Revenue Growth
  • GNFT 175.45
  • XBIT N/A
  • 52 Week Low
  • GNFT $2.97
  • XBIT $3.51
  • 52 Week High
  • GNFT $6.13
  • XBIT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 70.40
  • XBIT 51.00
  • Support Level
  • GNFT $5.41
  • XBIT $6.74
  • Resistance Level
  • GNFT $5.84
  • XBIT $7.72
  • Average True Range (ATR)
  • GNFT 0.29
  • XBIT 0.46
  • MACD
  • GNFT 0.05
  • XBIT -0.01
  • Stochastic Oscillator
  • GNFT 100.00
  • XBIT 49.17

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: